Oncology Division

Neha Mehta-Shah, MD

Assistant Professor
Department of Medicine
Oncology Division
Medical Oncology

Clinical Interests

  • Non-Hodgkin lymphoma
  • Hodgkin lymphoma
  • T/NK-cell lymphomas


  • 314-362-5654 (tel)
  • 314-747-5123 (fax)
  • 11th Floor Mid-Campus Center (office)
  • Division of Oncology
    Campus Box 8056
    Washington University Medical School
    660 South Euclid Avenue
    St. Louis, MO 63110


  • Nivolumab Combined With Brentuximab Vedotin for Relapsed/Refractory Primary Mediastinal Large B-Cell Lymphoma: Efficacy and Safety From the Phase II CheckMate 436 Study
    Zinzani PL, Santoro A, Gritti G, Brice P, Barr PM, Kuruvilla J, Cunningham D, Kline J, Johnson NA, Mehta-Shah N, Manley T, Francis S, Sharma M, Moskowitz AJ
    J Clin Oncol 2019 Aug 9:JCO1901492; [Epub ahead of print]
  • Novel Cell Adhesion/Migration Pathways Are Predictive Markers of HDAC Inhibitor Resistance in Cutaneous T Cell Lymphoma
    Andrews JM, Schmidt JA, Carson KR, Musiek AC, Mehta-Shah N, Payton JE
    EBioMedicine 2019 Aug;46:170-183
  • Multicenter Analysis of Outcomes in Blastic Plasmacytoid Dendritic Cell Neoplasm Offers a Pretargeted Therapy Benchmark
    Taylor J, Haddadin M, Upadhyay VA, Grussie E, Mehta-Shah N, Brunner AM, Louissaint A Jr, Lovitch SB, Dogan A, Fathi AT, Stone RM, Tallman MS, Rampal RK, Neuberg DS, Stevenson KE, Horwitz SM, Lane AA
    Blood 2019 Aug 22;134(8):678-687
  • Mogamulizumab-Associated Cutaneous Granulomatous Drug Eruption Mimicking Mycosis Fungoides but Possibly Indicating Durable Clinical Response
    Chen L, Carson KR, Staser KW, Mehta-Shah N, Schaffer A, Rosman IS, Musiek A
    JAMA Dermatol 2019 May 29; [Epub ahead of print]
  • Health-Related Quality of Life and Economic Implications of Cutaneous T-Cell Lymphoma
    Semenov YR, Rosenberg AR, Herbosa C, Mehta-Shah N, Musiek AC
    Br J Dermatol 2019 Mar 28; [Epub ahead of print]
  • Baseline and Interim Functional Imaging With PET Effectively Risk Stratifies Patients With Peripheral T-Cell Lymphoma
    Mehta-Shah N, Ito K, Bantilan K, Moskowitz AJ, Sauter C, Horwitz SM, Schoder H
    Blood Adv 2019 Jan 22;3(2):187-197
  • How I Treat Breast Implant-Associated Anaplastic Large Cell Lymphoma
    Mehta-Shah N, Clemens MW, Horwitz SM
    Blood 2018 Nov 1;132(18):1889-1898
  • Management of Relapsed/Refractory Classical Hodgkin Lymphoma in Transplant-Ineligible Patients
    Mehta-Shah N*, Bartlett NL* (*both authors contributed equally to this work)
    Blood 2018 Apr 12;131(15):1698-1703
  • NCCN Guidelines Insights: T-Cell Lymphomas, Version 2.2018
    Horwitz SM, Ansell SM, Ai WZ, Barnes J, Barta SK, Choi M, Clemens MW, Dogan A, Greer JP, Halwani A, Haverkos BM, Hoppe RT, Jacobsen E, Jagadeesh D, Kim YH, Lunning MA, Mehta A, Mehta-Shah N, Oki Y, Olsen EA, Pro B, Rajguru SA, Shanbhag S, Shustov A, Sokol L, Torka P, Wilcox R, William B, Zain J, Dwyer MA, Sundar H
    J Natl Compr Canc Netw 2018 Feb;16(2):123-135
  • Adult T-Cell Leukemia/Lymphoma
    Mehta-Shah N, Ratner L, Horwitz SM
    J Oncol Pract 2017 Aug;13(8):487-492
  • Uncommon Variants of T-Cell Lymphomas
    Mehta-Shah N, Horwitz S
    Hematol Oncol Clin North Am 2017 Apr;31(2):285-295
  • The Genetic Basis of Hepatosplenic T-Cell Lymphoma
    McKinney M, Moffitt AB, Gaulard P, Travert M, De Leval L, Nicolae A, Raffeld M, Jaffe ES, Pittaluga S, Xi L, Heavican T, Iqbal J, Belhadj K, Delfau-Larue MH, Fataccioli V, Czader MB, Lossos IS, Chapman-Fredricks JR, Richards KL, Fedoriw Y, Ondrejka SL, Hsi ED, Low L, Weisenburger D, Chan WC, Mehta-Shah N, Horwitz S, Bernal-Mizrachi L, Flowers CR, Beaven AW, Parihar M, Baseggio L, Parrens M, Moreau A, Sujobert P, Pilichowska M, Evens AM, Chadburn A, Au-Yeung RK, Srivastava G, Choi WW, Goodlad JR, Aurer I, Basic-Kinda S, Gascoyne RD, Davis NS, Li G, Zhang J, Rajagopalan D, Reddy A, Love C, Levy S, Zhuang Y, Datta J, Dunson DB, Dave SS
    Cancer Discov 2017 Apr;7(4):369-379
  • Managing Patients With Cutaneous B-Cell and T-Cell Lymphomas Other Than Mycosis Fungoides
    Kheterpal M, Mehta-Shah N, Virmani P, Myskowski PL, Moskowitz A, Horwitz SM
    Curr Hematol Malig Rep 2016 Jun;11(3):224-33
  • Lenalidomide in Adult T-Cell Leukemia/Lymphoma
    Mehta-Shah N, Horwitz SM
    J Clin Oncol 2016 Dec;34(34):4066-4067
  • Central Nervous System Involvement in T-Cell Lymphoma: A Single Center Experience
    Gurion R*, Mehta N*, Migliacci JC, Zelenetz A, Moskowitz A, Lunning M, Moskowitz C, Hamlin P, Horwitz S (*both authors contributed equally to this work)
    Acta Oncol 2016 May;55(5):561-6
  • Complete Surgical Excision Is Essential for the Management of Patients With Breast Implant-Associated Anaplastic Large-Cell Lymphoma
    Clemens MW, Medeiros LJ, Butler CE, Hunt KK, Fanale MA, Horwitz S, Weisenburger DD, Liu J, Morgan EA, Kanagal-Shamanna R, Parkash V, Ning J, Sohani AR, Ferry JA, Mehta-Shah N, Dogan A, Liu H, Thormann N, Di Napoli A, Lade S, Piccolini J, Reyes R, Williams T, McCarthy CM, Hanson SE, Nastoupil LJ, Gaur R, Oki Y, Young KH, Miranda RN
    J Clin Oncol 2016 Jan 10;34(2):160-8
  • Zebras and Hen's Teeth: Recognition and Management of Rare T and NK Lymphomas
    Mehta-Shah N, Horwitz S
    Hematology Am Soc Hematol Educ Program 2015;2015:545-9
  • Therapy for Peripheral T-Cell Lymphomas: Where We Are and Where We Hope to Be
    Mehta-Shah N, Horwitz S
    Oncology (Williston Park) 2015 Aug;29(8):558-9
  • Novel Targeted Therapies in Diffuse Large B-Cell Lymphoma
    Mehta-Shah N, Younes A
    Semin Hematol 2015 Apr;52(2):126-37
  • Adnexal Mass Secondary to Extranodal Marginal Zone Lymphoma of Mucosa-Associated Lymphoid Tissue (MALT Lymphoma) With Associated Amyloid Deposition
    Mehta N, Schoder H, Chiu A, Schoolmeester JK, Portlock C
    BMJ Case Rep 2014 Nov 14;2014 pii: bcr2014206699
  • A Retrospective Analysis of Peripheral T-Cell Lymphoma Treated With the Intention to Transplant in the First Remission
    Mehta N, Maragulia JC, Moskowitz A, Hamlin PA, Lunning MA, Moskowitz CH, Zelenetz A, Matasar MJ, Sauter C, Goldberg J, Horwitz SM
    Clin Lymphoma Myeloma Leuk 2013 Dec;13(6):664-70
  • Bexarotene Is Active Against Subcutaneous Panniculitis-Like T-Cell Lymphoma in Adult and Pediatric Populations
    Mehta N, Wayne AS, Kim YH, Hale GA, Alvarado CS, Myskowski P, Jaffe ES, Busam KJ, Pulitzer M, Zwerner J, Horwitz S
    Clin Lymphoma Myeloma Leuk 2012 Feb;12(1):20-5
  • Alemtuzumab for Relapsed and Refractory Erythrodermic Cutaneous T-Cell Lymphoma: A Single Institution Experience From the Robert H. Lurie Comprehensive Cancer Center
    Querfeld C*, Mehta N*, Rosen ST, Guitart J, Rademaker A, Gerami P, Kuzel TM (*both authors contributed equally to this work)
    Leuk Lymphoma 2009 Dec;50(12):1969-76